These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1375668)

  • 1. [Progress in hematological malignancy of aged--therapy of malignant lymphoma in aged].
    Mori M
    Nihon Ronen Igakkai Zasshi; 1992 Mar; 29(3):157-60. PubMed ID: 1375668
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group.
    Vose JM; Anderson JR; Bierman PJ; Bast M; Weisenburger D; Chan WC; Bishop MR; Armitage JO
    Semin Hematol; 1994 Apr; 31(2 Suppl 3):4-8. PubMed ID: 7521065
    [No Abstract]   [Full Text] [Related]  

  • 3. Long term outcome of localized aggressive non-Hodgkin lymphoma treated with a short weekly chemotherapy regimen (doxorubicin, cyclophosphamide, bleomycin, vincristine, and prednisone) and involved field radiotherapy: result of a Gruppo Italiano Multiregionale per lo Studio dei Linfomi e Leucenie (GIMURELL) study.
    Cabras MG; Mamusa AM; Vitolo U; Freilone R R; Dessalvi P; Orsucci L; Tonso A; Levis A; Liberati M; Lay G; Angelucci E
    Leuk Lymphoma; 2009 Sep; 50(9):1475-81. PubMed ID: 19579074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [High-dose chemotherapy followed by autologous stem cell transplantation in non-Hodgkin's lymphoma].
    Provencio M; Fayad LE
    Med Clin (Barc); 2008 Jan; 130(2):60-5. PubMed ID: 18221676
    [No Abstract]   [Full Text] [Related]  

  • 5. CHOP versus intensive regimens in non-Hodgkin's lymphoma.
    Longo DL; DeVita VT; Young RC
    N Engl J Med; 1993 Aug; 329(8):580-1; author reply 581-2. PubMed ID: 7687747
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of malignant lymphoma with extranodal lesions--current trends and new strategies in chemotherapy].
    Okumura H
    Rinsho Ketsueki; 1999 Mar; 40(3):196-8. PubMed ID: 10222625
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent progress in the therapeutic strategy for follicular lymphoma and mantle cell lymphoma].
    Ogura M
    Rinsho Ketsueki; 2006 Jun; 47(6):495-512. PubMed ID: 16862978
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of localized lymphoma.
    Hoecht S; Hinkelbein W
    N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15948267
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of localized lymphoma.
    Adli M; Sevinc A; Kalender ME
    N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15948268
    [No Abstract]   [Full Text] [Related]  

  • 10. Defining the stages of aggressive non-Hodgkin's lymphoma--a work in progress.
    Armitage JO
    N Engl J Med; 2005 Mar; 352(12):1250-2. PubMed ID: 15788502
    [No Abstract]   [Full Text] [Related]  

  • 11. [Therapeutic results and evolution of Black African patients with follicular lymphoma: Ivory Coast experience].
    Koffi G; Kouakou B; Ndiaye FS; Ndathz E; Sanogo I; Sangare A
    Bull Cancer; 2007 Oct; 94(10):902-6. PubMed ID: 17964984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Problems of cancer treatment in the elderly from the viewpoint of the chemotherapist--focusing on malignant lymphomas as a model of chemotherapy].
    Oyama A; Suzuki H; Ogura M
    Gan To Kagaku Ryoho; 1990 Apr; 17(4 Pt 2):858-61. PubMed ID: 2188607
    [No Abstract]   [Full Text] [Related]  

  • 13. [The choice of second-line chemotherapy for malignant lymphoma].
    Ikeda T; Hotta T
    Gan To Kagaku Ryoho; 2005 Jan; 32(1):6-10. PubMed ID: 15675573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic factors of follicular lymphoma treated with combination chemotherapy].
    Niitsu N; Umeda M
    Rinsho Ketsueki; 1997 Jun; 38(6):496-504. PubMed ID: 9248325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of the indolent non-Hodgkin's lymphomas.
    Portlock CS
    Semin Oncol; 1980 Sep; 7(3):292-301. PubMed ID: 6158100
    [No Abstract]   [Full Text] [Related]  

  • 16. Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features.
    Rodriguez J; McLaughlin P; Hagemeister FB; Fayad L; Rodriguez MA; Santiago M; Hess M; Romaguera J; Cabanillas F
    Blood; 1999 Apr; 93(7):2202-7. PubMed ID: 10090928
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of localized lymphoma.
    Tanvetyanon T
    N Engl J Med; 2005 Jun; 352(23):2449-51; author reply 2449-51. PubMed ID: 15944432
    [No Abstract]   [Full Text] [Related]  

  • 18. Prospectively randomized clinical trial of three intensive chemotherapy regimens for the treatment of advanced unfavorable histology non-Hodgkin's lymphoma.
    O'Connell MJ; Harrington DP; Earle JD; Johnson GJ; Glick JH; Carbone PP; Creech RH; Neiman RS; Mann RB; Silverstein MN
    J Clin Oncol; 1987 Sep; 5(9):1329-39. PubMed ID: 2442322
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma.
    Fisher RI; Gaynor ER; Dahlberg S; Oken MM; Grogan TM; Mize EM; Glick JH; Coltman CA; Miller TP
    N Engl J Med; 1993 Apr; 328(14):1002-6. PubMed ID: 7680764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-dose therapy for follicular lymphoma revisited: not if, but when?
    Lister TA
    J Clin Oncol; 2003 Nov; 21(21):3894-6. PubMed ID: 14517186
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.